The study uncovers a unique reparative function of regulatory T cells (Tregs) in the process of fracture healing, a discovery that adds a new dimension to our understanding of the immune response in tissue regeneration.
Janssen seeks EMA approval for RYBREVANT in NSCLC
Share this article The Rybrevant regimen is intended for treating advanced non-small cell lung cancer. Credit: Minerva Studio / Shutterstock.com. The Janssen Pharmaceutical Companies of